Characteristics of patients who are initiated on long-acting buprenorphine (Buvidal®) in France: A retrospective cross-sectional study
Résumé
The long-acting buprenorphine Buvidal ® is a recent type of opioid agonist treatment (OAT) used for opioid use disorder (OUD). It was initially suggested to preferentially use Buvidal ® for specific OUD populations, including people in prison, or patients in recovery and on sublingual
Domaines
Psychiatrie et santé mentale
Fichier principal
Characteristics of patients who are initiated on long-acting buprenorphine (Buvidal®) in France= A retrospective cross-sectional study.pdf (477)
Télécharger le fichier
Origine | Fichiers éditeurs autorisés sur une archive ouverte |
---|---|
licence |